Table 1.
Baseline characteristics of the study population
| Characteristics
|
Study initiation (n=12) | Prior to second treatmenta (n=12) |
|---|---|---|
| End point – mean (SD) | ||
|
| ||
| Tear break-up time (seconds) | 3.1 (0.8) | 5.0 (1.1) |
| Meibomian gland score | 6.3 (3.6) | 22.0 (8.2) |
| Corneal staining score | 3.5 (1.8) | 0.2 (0.4) |
| Conjunctival staining score | 3.7 (2.5) | 1.0 (1.4) |
| SPEED score | 15.7 (5.2) | 10.0 (5.4) |
| SANDE score | 64.9 (25.9) | 47.1 (25.8) |
| OSDI score | 41.0 (18.4) | 31.4 (18.6) |
Note:
a
Baseline characteristics of the study population at the Month 7 clinic visit prior to the second treatment by the TearCare® system.
Abbreviations: OSDI, Ocular Surface Disease Index; SANDE, Symptom Assessment in Dry Eye; SPEED, Standard Patient Evaluation for Eye Dryness.